ScholarIQanswers from OpenAlex & ORCID
Ali Zarrabi
ResearcherPublications, citations & collaboration network
Ali Zarrabi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ali Zarrabi have?
ScholarIQindexed works
Ali Zarrabi has 444 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ali Zarrabi have?
ScholarIQcitation count
Ali Zarrabi has 22,617 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ali Zarrabi?
ScholarIQh-index
Ali Zarrabi has an h-index of 82 in OpenAlex.
What is the i10-index of Ali Zarrabi?
ScholarIQi10-index
Ali Zarrabi has an i10-index of 317 in OpenAlex.
What is the ORCID of Ali Zarrabi?
ScholarIQorcid
The ORCID for Ali Zarrabi is on the source record.
What is the OpenAlex record for Ali Zarrabi?
ScholarIQopenalex
The OpenAlex for Ali Zarrabi is on the source record.
What are the most-cited papers on Ali Zarrabi?
ScholarIQmost cited works
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, Amirhossein Zabolian, Hossein Saleki, Mohamad Javad Naghdi, Sina Sabet, Mohammad Amin Khoshbakht, Mehrdad Hashemi, Kiavash Hushmandi, Gautam Sethi, Ali Zarrabi, Alan Prem Kumar, Shing Cheng Tan, Marios Papadakis, Αθανάσιος Αλεξίου, Md Asiful Islam, Ebrahim Mostafavi, Milad Ashrafizadeh
RETRACTED: AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, Amirhossein Zabolian, Shima Mohammadi, Farima Fakhri, Mehrdad Hashemi, Kiavash Hushmandi, Milad Ashrafizadeh, Ali Zarrabi, Yavuz Nuri Ertaş, Sepideh Mirzaei, Saeed Samarghandian
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, Ashkan Bigham, Esmaeel Sharifi, Navid Rabiee, Ana Cláudia Paiva‐Santos, Alan Prem Kumar, Shing Cheng Tan, Kiavash Hushmandi, Jun Ren, Ehsan Nazarzadeh Zare, Pooyan Makvandi
RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Hossein Saleki, Seyed Omid Sharifzadeh, Leyla Soleymani, Salman Daneshi, Kiavash Hushmandi, Haroon Khan, Alan Prem Kumar, Amir Reza Aref, Saeed Samarghandian